You just read:

SELLAS Life Sciences Announces FDA Orphan Drug Designation for WT1 Cancer Vaccine in Patients with Malignant Pleural Mesothelioma

News provided by

SELLAS Life Sciences Group

Feb 29, 2016, 08:00 EST